Sherlock Biosciences Research Associate Joel Mowatt in the lab. The Cambridge, Mass. company develops coronavirus tests using CRISPR and synthetic biology. (Jesse Costa/WBUR)
06:53Jul 10, 2020

CRISPR Comes To COVID: A Pandemic Pivot And The Push For A Simple Coronavirus Test

With coronavirus tests in short supply around the country, the revolutionary gene-editing tool CRISPR could help, and a Cambridge, Mass. company is trying to develop quick, cheap, accurate tests that could help with reopening.

Health & Science News From NPR


Support the news

More From CommonHealth

CommonHealth Classics